HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Friday, 15 November 2013

Recents CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  25 papers were listed this time. Here's a few in our areas of research interest:

Eggington S, Valldeoriola F, Chaudhuri KR, et al. The  cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease. J Neurol. 2013 Oct 25. [Epub ahead of print] PubMed PMID: 24158271.

Zhuo X, Zhang P, Kahn HS, et al. Cost-Effectiveness of Alternative Thresholds of the Fasting Plasma Glucose Test to Identify the Target Population for Type 2 Diabetes Prevention in Adults Aged >=45 Years. Diabetes Care. 2013 Oct 17. [Epub ahead of print] PubMed PMID: 24135386.

Mezquita Raya P, Pérez A, et al. Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis  of Liraglutide Versus Sitagliptin. Diabetes Ther. 2013 Oct 17. [Epub ahead of print] PubMed PMID: 24132613. 

Please note: links are to full-text where available (i.e. open access articles) or to PubMed. ScHARR staff only – if you require help accessing any of the articles mentioned in this blog, please contact Kath Dickinson, Information Specialist at ScHARR.